Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Integrated Prospective Analysis of Radiomic and Immunologic Signatures in Nasopharyngeal Carcinoma Treated With Proton or Photon Radiotherapy

NCT07232680 is registered in ClinicalTrials.gov with Cheng-En Hsieh as lead sponsor.

NCT NCT07232680
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07232680 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Integrated Prospective Analysis of Radiomic and Immunologic Signatures in Nasopharyngeal Carcinoma Treated With Proton or Photon Radiotherapy
Lead sponsor
Cheng-En Hsieh
Phase
Observational
Overall status
Recruiting
Start date
November 20, 2025
Completion date
August 15, 2034
Enrollment
500 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

nasopharyngeal cancinoma (npc), npc patients